Abstract
The antimicrobial resistance crisis has been amplified by the COVID-19 pandemic.1 However, under its zero-COVID policy, China had a decline in antibiotic consumption,2 because the intensive non-pharmaceutical interventions aimed at controlling COVID-19 also prevented the spread of other airborne diseases and their subsequent infections. China also tightened drug selling to treat COVID-19-related symptoms as part of its zero-COVID efforts, which contributed to lessened self-medication with antibiotics.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
